Heartland Bank & Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,428
Closed -$771K 151
2024
Q1
$771K Sell
1,428
-5
-0.3% -$2.73K 0.45% 55
2023
Q4
$795K Sell
1,433
-46
-3% -$21.6K 0.55% 45
2023
Q3
$647K Sell
1,479
-372
-20% -$186K 0.51% 55
2023
Q2
$930K Sell
1,851
-35
-2% -$16.8K 0.73% 34
2023
Q1
$943K Buy
+1,886
New +$903K 0.71% 37
2022
Q1
Sell
-938
Closed -$618K 136
2021
Q4
$618K Buy
938
+20
+2% +$12.6K 0.46% 63
2021
Q3
$571K Buy
918
+68
+8% +$45.7K 0.49% 63
2021
Q2
$537K Sell
850
-17
-2% -$9.39K 0.49% 60
2021
Q1
$424K Buy
+867
New +$434K 0.39% 72

Other funds holding IDXX

Heartland Bank & Trust's IDXX Position: Q2 2024 in Review

Heartland Bank & Trust sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 1,428 shares — an estimated $771K sold.

Heartland Bank & Trust first reported a position in IDXX in Q1 2021 and held it in 9 quarters. The position peaked at $943K in Q1 2023. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Heartland Bank & Trust reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Heartland Bank & Trust sold 1,428 Idexx Laboratories shares in Q2 2024, an estimated $771K.
  • Heartland Bank & Trust first reported a position in Idexx Laboratories in Q1 2021 and held it in 9 quarters.
  • Heartland Bank & Trust's Idexx Laboratories position peaked at $943K in Q1 2023.
  • 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Heartland Bank & Trust's 13F filing for Q2 2024, filed 21 Aug 2024.